Literature DB >> 15327830

Overexpression of c-Jun induced by quercetin and resverol inhibits the expression and function of the androgen receptor in human prostate cancer cells.

Huiqing Yuan1, Yunqian Pan, Charles Y F Young.   

Abstract

Previously, we reported that quercetin and resveratrol inhibit the function of androgen receptor (AR). Further studies showed that these two polyphenols caused an increase in expression of c-Jun as well as its phosphorylated form in a dose-dependent manner in prostatic cell lines. Gel shift assay showed that induced c-Jun has specific DNA binding activity. Transient transfections demonstrated that c-Jun repressed prostate-specific antigen promoter activity and transcriptional activity of the AR promoter. These results support a mechanism in which overexpressed c-Jun mediates inhibitory effect on the function of AR. These polyphenols might potentially be useful in prostate cancer prevention.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15327830     DOI: 10.1016/j.canlet.2004.04.003

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  13 in total

1.  Quercetin-induced growth inhibition and cell death in prostatic carcinoma cells (PC-3) are associated with increase in p21 and hypophosphorylated retinoblastoma proteins expression.

Authors:  M R Vijayababu; P Kanagaraj; A Arunkumar; R Ilangovan; M M Aruldhas; J Arunakaran
Journal:  J Cancer Res Clin Oncol       Date:  2005-11-01       Impact factor: 4.553

2.  Suppression of the androgen receptor function by quercetin through protein-protein interactions of Sp1, c-Jun, and the androgen receptor in human prostate cancer cells.

Authors:  Huiqing Yuan; Charles Y F Young; Yuanyuan Tian; Zhifang Liu; Mengye Zhang; Hongxiang Lou
Journal:  Mol Cell Biochem       Date:  2010-02-11       Impact factor: 3.396

3.  Regulation of heat shock protein 70-1 expression by androgen receptor and its signaling in human prostate cancer cells.

Authors:  Shan Lu; Zongqin Tan; Matt Wortman; Shan Lu; Zhongyun Dong
Journal:  Int J Oncol       Date:  2010-02       Impact factor: 5.650

4.  Sodium selenite inhibits interleukin-6-mediated androgen receptor activation in prostate cancer cells via upregulation of c-Jun.

Authors:  Mozammel H Gazi; Aiyu Gong; Krishna V Donkena; Charles Y F Young
Journal:  Clin Chim Acta       Date:  2007-02-11       Impact factor: 3.786

5.  The inflammation-related gene S100A12 is positively regulated by C/EBPβ and AP-1 in pigs.

Authors:  Xinyun Li; Juan Tang; Jing Xu; Mengjin Zhu; Jianhua Cao; Ying Liu; Mei Yu; Shuhong Zhao
Journal:  Int J Mol Sci       Date:  2014-08-08       Impact factor: 5.923

6.  Repressive effects of resveratrol on androgen receptor transcriptional activity.

Authors:  Wen-feng Shi; Melanie Leong; Ellen Cho; Joseph Farrell; Han-chun Chen; Jun Tian; Dianzheng Zhang
Journal:  PLoS One       Date:  2009-10-09       Impact factor: 3.240

7.  Mathematical model of a telomerase transcriptional regulatory network developed by cell-based screening: analysis of inhibitor effects and telomerase expression mechanisms.

Authors:  Alan E Bilsland; Katrina Stevenson; Yu Liu; Stacey Hoare; Claire J Cairney; Jon Roffey; W Nicol Keith
Journal:  PLoS Comput Biol       Date:  2014-02-13       Impact factor: 4.475

Review 8.  Anti-androgenic effects of flavonols in prostate cancer.

Authors:  Tristan Boam
Journal:  Ecancermedicalscience       Date:  2015-10-22

9.  Resveratrol enhances polyubiquitination-mediated ARV7 degradation in prostate cancer cells.

Authors:  Sarah Wilson; Lucia Cavero; Dali Tong; Qiuli Liu; Kyla Geary; Nicholas Talamonti; Jing Xu; Junjiang Fu; Jun Jiang; Dianzheng Zhang
Journal:  Oncotarget       Date:  2017-05-19

Review 10.  Natural Compounds in Prostate Cancer Prevention and Treatment: Mechanisms of Action and Molecular Targets.

Authors:  Fabrizio Fontana; Michela Raimondi; Monica Marzagalli; Alessandro Di Domizio; Patrizia Limonta
Journal:  Cells       Date:  2020-02-18       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.